BILL ANALYSIS

HR7887

NEUTRAL

To prohibit stock sales by senior bank executives in certain circumstances.

HR7887 (To prohibit stock sales by senior bank executives in certain circumstances.) has been assessed with a neutral outlook for investors. This legislation directly affects Bank of America ($BAC), Citigroup ($C), Goldman Sachs ($GS) and JPMorgan Chase ($JPM) and 2 other tickers. The primary sectors impacted are Finance. View the full bill text on Congress.gov.

neutral

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

HR7887 is a single-sponsor bill with zero legislative momentum — referred to committee with no cosponsors and no hearings.

The bill authorizes zero spending and creates no new tax, no new mandate on bank operations, and no change to lending or capital rules.

All six major bank stocks traded within normal ranges in April 2026 with gains of 2-14% driven by sector-wide trends, not this legislation.

The provision only activates if a bank's CAMELS rating drops to 3+, which no major bank currently has publicly disclosed.

Zero near-term market impact. This is a governance-focused bill, not a sector-moving financial regulation.

How HR7887 Affects the Market

No market implications from HR7887. All six major bank stocks — $JPM at $310.24, $BAC at $53.02, $WFC at $81.47, $C at $127.97, $GS at $913.68, and $MS at $187.30 — are trading within their 52-week ranges and have shown no event-driven volatility linked to this legislation. The 5-14% 30-day gains across the sector reflect broader macroeconomic factors (interest rate expectations, loan growth, capital return plans), not legislative risk. Retail investors should not price this bill into any position.

Bill Details

Metric	Value
Bill Number	HR7887
Market Sentiment	neutral
Event Date	March 9, 2026
Affected Sectors	Finance
Affected Stocks	Bank of America ($BAC), Citigroup ($C), Goldman Sachs ($GS), JPMorgan Chase ($JPM), Morgan Stanley ($MS), Wells Fargo ($WFC)
Source	View on Congress.gov →

Summary

HR7887 is a single-sponsor early-stage bill referred to committee with no legislative momentum. It would prohibit stock sales by senior executives at large banks only if the bank receives a poor regulatory rating. The bill has zero market impact today. All six major bank stocks traded within normal ranges in April 2026 with no event-driven volatility tied to this legislation.

Full AI Market Analysis

On March 9, 2026, Representative Maxine Waters (D-CA) introduced HR7887, the Incentivizing Safe and Sound Banking Act. The bill was referred to the House Committee on Financial Services and has taken no further action since its introduction. It has zero cosponsors. As with all early-stage bills in the 119th Congress, the legislative path is uncertain and likely requires committee hearings, markup, floor passage in the House, companion legislation in the Senate, and presidential action or veto. The bill authorizes no spending and appropriates no funds. It imposes a behavioral restriction on senior executives at bank holding companies and banks with more than $50 billion in consolidated assets. Under the bill, if a covered banking institution receives a composite or component CAMELS rating of 3, 4, or 5, or receives an unresolved 'matter requiring immediate attention' (MRIA) supervisory notice, senior executive officers are automatically prohibited from selling any stock they received as compensation until the matter is resolved to the satisfaction of the applicable federal banking agency. The FDIC would also gain discretionary authority to impose similar stock sale prohibitions during cease-and-desist proceedings. This bill does not change any bank's earnings, revenue, capital requirements, lending capacity, or operating structure. It is a governance provision affecting executive compensation liquidity. The six largest U.S. bank holding companies — JPMorgan Chase ($JPM), Bank of America ($BAC), Wells Fargo ($WFC), Citigroup ($C), Goldman Sachs ($GS), and Morgan Stanley ($MS) — all have >$50B in assets and are covered entities. As of April 30, 2026, none of these banks have a publicly known composite CAMELS rating of 3 or above, nor an unresolved MRIA that would trigger the automatic prohibition. The provision only becomes economically relevant if a bank's regulatory standing significantly deteriorates. Real market data confirms zero market reaction. As of April 30, 2026, JPMorgan closed at $310.24 (30-day change +5.46%), Bank of America at $53.02 (+8.76%), Wells Fargo at $81.47 (+2.34%), Citigroup at $127.97 (+12.84%), Goldman Sachs at $913.68 (+8.00%), and Morgan Stanley at $187.30 (+13.81%). All six stocks are within their 52-week ranges and their 30-day gains are consistent with the broader banking sector rally in early 2026 — not driven by this bill. No event-driven volatility, no abnormal volume, no gap moves on March 9 or any subsequent date. For this bill to become law, it must pass committee markup, pass the full House, find a Senate companion bill, pass the Senate, and be signed by the President. With a single Democratic sponsor in a divided 119th Congress, and no cosponsors or committee hearings scheduled, passage probability in the current congress is negligible.